Circular Frame Strategies for Ankle and Hindfoot Charcot Reconstruction
Foot and Ankle Clinics · 2024
DOI: 10.1016/j.fcl.2024.08.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Foot and Ankle Clinics, 2024. Verfasst von Om Lahoti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Department, King's College Hospital, London, UK. Electronic address: omlahoti@nhs.net. Hauptthemen laut MEDLINE: Arthropathy, Neurogenic, External Fixators, Ankle Joint. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Ankle and hindfoot Charcot neuroarthropathy is a complex problem and should be carefully assessed and managed to prevent morbidity and limb loss. Circular frames offer a range of options to address a wide variety of clinical situations and also complement internal fixation techniques. Multidisciplinary care and specialist skills to provide frame treatment are essential for a successful outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopaedic Department, King's College Hospital, London, UK. Electronic address: omlahoti@nhs.net.
- Orthopaedic Department, King's College Hospital, London, UK. Electronic address: https://twitter.com/Charmilie_C.
- Orthopaedic Department, King's College Hospital, London, UK; University of Southern Denmark. Electronic address: https://twitter.com/VenuKavarthapu.
Zitieren
APA
Lahoti, O., Chandrakumar, C., & Kavarthapu, V. (2024). Circular Frame Strategies for Ankle and Hindfoot Charcot Reconstruction. Foot and Ankle Clinics. https://doi.org/10.1016/j.fcl.2024.08.009
Vancouver
Lahoti O, Chandrakumar C, Kavarthapu V. Circular Frame Strategies for Ankle and Hindfoot Charcot Reconstruction. Foot and Ankle Clinics. 2024. doi:10.1016/j.fcl.2024.08.009
BibTeX
@article{Lahoti2024,
author = {Lahoti, Om and Chandrakumar, Charmilie and Kavarthapu, Venu},
title = {Circular Frame Strategies for Ankle and Hindfoot Charcot Reconstruction},
journal = {Foot and Ankle Clinics},
year = {2024},
doi = {10.1016/j.fcl.2024.08.009}
}
EUVIMED